Implanon Nxt (Etonogestrel)

Etonogestrel is a progestin used in hormonal contraception to prevent pregnancy.

• Contraception: provides continuous birth control for up to three years without daily dosing.
• Long‑acting reversible contraception: offers a reliable, implantable method that can be removed when pregnancy is desired.
• Hormonal birth control: suppresses ovulation and thickens cervical mucus to prevent fertilization.

• Etonogestrel binds to progesterone receptors in the hypothalamus and pituitary, inhibiting the luteinizing hormone surge that triggers ovulation. The sustained release from the subcutaneous implant maintains plasma concentrations that also thicken cervical mucus and alter the endometrial lining, creating an environment unfavorable for sperm penetration and implantation. By maintaining a steady hormonal level, the implant reduces the variability seen with oral contraceptives and ensures consistent suppression of the reproductive axis throughout the dosing interval.

Etonogestrel implants may be associated with a range of adverse reactions, varying in frequency and severity.

Common Side Effects

• Irregular bleeding or spotting
• Amenorrhea (absence of periods)
• Headache
• Breast tenderness
• Acne or oily skin
• Weight gain

Serious or Rare Side Effects

• Ectopic pregnancy
• Pelvic inflammatory disease
• Implant site infection
• Severe allergic reaction (anaphylaxis)
• Thromboembolic events (deep vein thrombosis, pulmonary embolism)
• Hormone‑dependent tumor progression (rare)

Before initiating Implanon Nxt, healthcare providers should evaluate patient history and follow specific safety measures.

• Medical assessment: screen for active liver disease, thromboembolic disorders, or hormone‑sensitive cancers.
• Pregnancy status: confirm the patient is not pregnant prior to insertion.
• Breastfeeding: discuss potential benefits and risks with lactating women.
• Medication review: identify drugs that may reduce contraceptive effectiveness.
• Follow‑up care: schedule visits to check implant position and manage bleeding patterns.
• Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Etonogestrel’s contraceptive efficacy can be altered by concomitant medications that affect hormone metabolism.

Major Interactions (Avoid)

• Enzyme inducers (e.g., rifampin, carbamazepine, phenytoin): may significantly lower etonogestrel levels.
• Protease inhibitor antiretrovirals: can interfere with hormone metabolism.

Moderate Interactions (Monitor Closely)

• Antifungal azoles (e.g., ketoconazole): may increase hormone concentrations.
• St. John’s wort herbal supplement: may reduce contraceptive effectiveness.
• Certain antibiotics (e.g., ampicillin): generally minimal effect but monitor for breakthrough bleeding.